Nanox to Report Third Quarter 2025 Financial Results on November 20, 2025
Nanox (Nasdaq: NNOX) will report third quarter 2025 financial results for the period ended September 30, 2025 on Thursday, November 20, 2025 before market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nanox (Nasdaq: NNOX) will report third quarter 2025 financial results for the period ended September 30, 2025 on Thursday, November 20, 2025 before market open. Management will host a conference call and live webcast on the same day at 8:30 a.m. ET to review results and provide a business update. Registration and the live webcast will be available via the company website in the Investor Relations Events and Presentations section.
Details
News Market Reaction – NNOX
On Nov 10, the first trading day after this news, NNOX closed 1.64% below the previous close.
Data tracked by StockTitan Argus for the Nov 10 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PETACH TIKVA, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2025, before market open on Thursday, November 20, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Interested parties may register for the conference call using the following link: Nanox Q3 2025 Conference Call. The live webcast of the conference call may be accessed by using the following link: Nanox Q3 2025 Webcast.
The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.
Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, with an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision.
Contacts
Investor Contact
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Media Contact
ICR Healthcare
NanoxPR@icrinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.